Volume 129, Issue 2, Pages (August 2005)

Slides:

Advertisements

Similar presentations

Overview and pathogenesis of celiac disease Martin F. Kagnoff Gastroenterology Volume 128, Issue 4, Pages S10-S18 (April 2005) DOI: /j.gastro

Advertisements

Patients With NASH and Cryptogenic Cirrhosis Are Less Likely Than Those With Hepatitis C to Receive Liver Transplants Jacqueline G. O'Leary, Carmen Landaverde,

Two decades of pediatric lung transplant in the United States: Have we improved? Farhan Zafar, MD, Jeffrey S. Heinle, MD, Marc G. Schecter, MD, Joseph.

Volume 116, Issue 2, Pages (February 1999)

Hemochromatosis: Genetic Testing and Clinical Practice

Paul C. Adams, Leah Passmore, Subrata Chakrabarti, David M

Volume 133, Issue 2, Pages (August 2007)

Volume 152, Issue 4, Pages (March 2017)

Steatosis Is a Cofactor in Liver Injury in Hemochromatosis

HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence Claus Hellerbrand, Andreas Pöppl, Arndt Hartmann, Jürgen Schölmerich,

Outcomes Among Living Liver Donors

Improved Virologic Response in Chronic Hepatitis C Genotype 4 Treated With Nitazoxanide, Peginterferon, and Ribavirin Jean–François Rossignol, Asem Elfert,

Roberts Brown, Jean C. Emond Gastroenterology

Ira J. Fox, Stephen C. Strom Gastroenterology

Volume 147, Issue 1, Pages e4 (July 2014)

David J. Brenner, Eric J. Hall, Rochelle E. Curtis, Elaine Ron

Volume 137, Issue 3, Pages e1 (September 2009)

Donor Morbidity After Living Donation for Liver Transplantation

Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients David Schoemaker, Robert Black, Lynne.

The Changing Liver Transplant Waitlist: An Emerging Liver Purgatory?

Volume 153, Issue 3, Pages e16-e17 (September 2017)

Volume 135, Issue 4, Pages (October 2008)

A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote Daniel F. Wallace, James S. Dooley, Ann P.

Volume 120, Issue 3, Pages (February 2001)

Volume 154, Issue 4, Pages (March 2018)

Yasuhiko Sugawara, Masatoshi Makuuchi

Racial and Ethnic Differences in Presentation, Etiology, and Outcomes of Acute Liver Failure in the United States Kimberly A. Forde, K. Rajender Reddy,

Volume 155, Issue 5, Pages e2 (November 2018)

Volume 155, Issue 5, Pages (November 2018)

The Natural History of Small-Duct Primary Sclerosing Cholangitis

Current and Future Trends in Liver Transplantation in Europe

Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease David A. Johnson, M.Brian Fennerty

Volume 129, Issue 1, Pages (July 2005)

Michael Charlton Clinical Gastroenterology and Hepatology

Volume 119, Issue 2, Pages (August 2000)

Volume 133, Issue 2, Pages (August 2007)

Volume 128, Issue 2, Pages (February 2005)

Predicting Iron Overload in Hyperferritinemia

Volume 133, Issue 2, Pages (August 2007)

Volume 133, Issue 6, Pages (December 2007)

Volume 131, Issue 2, Pages (August 2006)

Ashwin N. Ananthakrishnan, David Lieberman Gastroenterology

Covering the Cover Gastroenterology

Volume 148, Issue 3, Pages (March 2015)

Presentation of the Julius M. Friedenwald Medal to Emmet B. Keeffe, MD

Prevalence and Treatment of Hepatitis C Virus Genotypes 4, 5, and 6

Amer A. Alkhatib, MD, Rodney W. Stuart, MD, Ronald L. Weiss, MD

Volume 149, Issue 6, Pages (November 2015)

Hemochromatosis: Diagnosis and management

Covering the Cover Gastroenterology

Volume 141, Issue 4, Pages (October 2011)

Chronic Diarrhea Clinical Gastroenterology and Hepatology

Volume 135, Issue 4, Pages (October 2008)

Volume 122, Issue 4, Pages (April 2002)

Liver Transplantation for Hepatocellular Carcinoma

The North American Study for the Treatment of Refractory Ascites

Michelle Maria Pietzak Gastroenterology

Volume 155, Issue 6, Pages (December 2018)

Volume 139, Issue 6, Pages e1 (December 2010)

End-Stage Liver Disease in 2008: Finally a Glass Half Full

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

Volume 141, Issue 5, Pages (November 2011)

The Journal of Thoracic and Cardiovascular Surgery

Patients With NASH and Cryptogenic Cirrhosis Are Less Likely Than Those With Hepatitis C to Receive Liver Transplants Jacqueline G. O'Leary, Carmen Landaverde,

The Future of Endoscopic Retrograde Cholangiopancreatography

Controversies in Liver Transplantation for Hepatitis C

Volume 135, Issue 5, Pages (November 2008)

Statin Use Is Associated With a Decreased Risk of Barrett’s Esophagus

Yu–Xiao Yang, Sean Hennessy, James D. Lewis Gastroenterology

Volume 129, Issue 2, Pages (August 2005)

Presentation transcript:

Volume 129, Issue 2, Pages 494-503 (August 2005) Survival After Liver Transplantation in Patients With Hepatic Iron Overload: The National Hemochromatosis Transplant Registry Kris V. Kowdley, David J. Brandhagen, Robert G. Gish, Nathan M. Bass, Jeffrey Weinstein, Michael L. Schilsky, Robert J. Fontana, Timothy McCashland, Scott J. Cotler, Bruce R. Bacon, Emmet B. Keeffe, Fredric Gordon, Nayak Polissar Gastroenterology Volume 129, Issue 2, Pages 494-503 (August 2005) DOI: 10.1053/j.gastro.2005.05.004 Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 1 Kaplan—Meier estimates for survival after liver transplantation in the overall cohort of patients with hepatic iron overload (n = 260). Gastroenterology 2005 129, 494-503DOI: (10.1053/j.gastro.2005.05.004) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 2 Kaplan—Meier estimates for survival after liver transplantation among patients based on HFE genotype. C282Y +/+, C282Y homozygous; CPD Het, C282Y/H63D compound heterozygote; Simple het, C282Y/wt or H63D/wt; Wt: wt/wt. Gastroenterology 2005 129, 494-503DOI: (10.1053/j.gastro.2005.05.004) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 3 Kaplan—Meier estimates for survival after liver transplantation among patients with HH (defined as C282Y homozygous or C282Y/H63D compound heterozygous [group 1 and group 2]) compared with HFE heterozygotes (C282Y/wt or H63D wt) and patients wild type for HFE [group 3 and group 4]. Gastroenterology 2005 129, 494-503DOI: (10.1053/j.gastro.2005.05.004) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 4 (A) Kaplan—Meier estimates for survival among patients with HII >1.9 compared with those with HII ≤1.9. There was no significant difference in survival between the 2 groups. (B) Kaplan—Meier estimates for survival among patients with hepatic iron concentration (HIC) >70 μmol/g dry weight compared with those with HIC ≤70 μmol/g dry weight. There was no significant difference in survival between the 2 groups. Gastroenterology 2005 129, 494-503DOI: (10.1053/j.gastro.2005.05.004) Copyright © 2005 American Gastroenterological Association Terms and Conditions